| In situ treatment with a TLR9 agonist virus‑like particle to promote immune responses against oral epithelial dysplasia progression | Yan Xu, Alexandra Mcmillan, Nikesh Gupta, Caitlin D. Lemke Miltner, Aseel O. Rataan, Sudartip Areecheewakul, Divya S. Bhat, Emily A. Lanzel, Sean M. Geary, Andrean L. Simons, George J. Weiner, Aliasger K. Salem | Cancer immunology, immunotherapy | ---- | ---- | 03-05-2025 |
| Targeting transforming growth factor-b1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential | ---- | ---- | 42 | Cancer Treatment and Research Communications | 2025-01-09 00:00:00 |
| Comparative pharmacological analysis of fam-trastuzumab deruxtecan-nxki and sacituzumab govitecan-hziy: Two recently developed chemotherapies in the crucial battle against breast cancer | ---- | ---- | 14 | Toxicology Reports | 2025-05-21 00:00:00 |
| Knowledge and awareness of breast cancer signs and symptoms among Jordanian women | ---- | ---- | 11 | Future Science OA | 2025-05-28 00:00:00 |
| Pre-treatment red cell index and metastasis status as independent predictors of overall survival in Jordanian breast cancer patients receiving chemotherapy | ---- | ---- | 15 | Toxicology Reports | 2025-06-19 00:00:00 |
| Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer | Haneen Amawi , Alaa M Hammad, F Scott Hall , Noor Hussein , Aseel O Rataan , Abeer Mrayyan , Taqwa Al-Kofahi , Ali Hmedat, Charles R Ashby, Amit K Tiwari | Cancer Biology and Medicine | ---- | ---- | 29-9-2025 |